These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Over the past decade, pharmaceutical maker Pfizer (NYSE: PFE) has severely lagged the market. Dividends reinvested aside, the stock is in the red over this period, while the S&P 5 ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best healthcare stocks with the highest upside. In a report ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Many analysts are picking healthcare stocks as indicators point to a potential rebound in the sector. Karen Finerman, CEO & ...

This lens points to three standouts in retail, healthcare, and consumer goods. One pairs a modest yield with rapid hikes ...

Cathie Wood, the chief executive officer of Ark Invest, can be somewhat of a polarizing figure, with some research indicating ...

Stock market crashes are scary, but they've always been followed by longer recovery periods. Intuitive Surgical is a leading ...

At 24/7 Wall St., we have closely followed dividend-paying stocks for over 15 years. With a growing audience of savvy Baby ...

Aurobindo Pharma stock analysis with support, resistance levels, F&O pointers, and trading strategy for potential profit.